chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Suspected vaccination failure/Fully vaccinated for shingles/vaccine hasn't stopped my outbreaks/This is the third time I have gotten; broken out with shingles/currently broken out again/vaccine hasn't stopped my outbreaks/This is the third time I have gotten; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had broken out with shingles a few times a year for years) and blister. Concurrent medical conditions included scar (have had scars on his/her side from blisters).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 24-June-2022 Reporter's comment: The case was reported by the patient via interactive digital media. The patient was broken out with shingles a few times a year for years.  The patient had scars on his/her side from the blisters.  The patient was fully vaccinated for shingles last year but the patient was currently broken out again.  The vaccine had not stopped the outbreaks at all.  This was the third time the patient had gotten them since the shots. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. Note: As there is no contact details available due which it was not possible to confirm whether scars on my side from the blisters was occurred before or after the vaccinations, therefore conservatively it was captured under medical condition as narrative chronology.
tempter goes to a102-103; ach all over; sweat like race horse; spiders coming out of the walls and the sky and I know its not the flu; Initial information received on 25-Nov-2020 regarding an unsolicited valid non-serious case received from a patient via social media.  This case involves patient (unknown demographics) whose tempter went to a102-103 (pyrexia), ach all over (pain), sweat like race horse (hyperhidrosis), spiders coming out of the walls and the sky and the patient knew its not the flu (unevaluable event) while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patients whose tempter went to a102-103 (pyrexia), ach all over (pain), sweat like race horse (hyperhidrosis), spiders coming out of the walls and the sky and the patient knew its not the flu (unevaluable event) unknown latency following the administration of INFLUENZA VACCINE. It was not reported if the patient received a corrective treatment.  The event outcome was unknown.
On 12/24/2020, around 10:30 PM, patient began experiencing shortness of breath. She also experienced rash, diarrhea, myalgias, chills and hives (hives began on 12/26/2020). The patient used an inhaler and took Claritin.
felt dizzy; dizzy and lightheaded when she woke up; Sore arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (felt dizzy; dizzy and lightheaded when she woke up) and VACCINATION SITE PAIN (Sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included HYDROCHLOROTHIAZIDE, CALCIUM, VITAMIN D NOS, VITAMIN C [ASCORBIC ACID], MULTIVITAMIN [ASCORBIC ACID;COLECALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE], BIOTIN and FISH OIL for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 06-Jan-2021, the patient experienced DIZZINESS (felt dizzy; dizzy and lightheaded when she woke up). In January 2021, VACCINATION SITE PAIN (Sore arm) had resolved. At the time of the report, DIZZINESS (felt dizzy; dizzy and lightheaded when she woke up) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
hospitalization with covid; 1 dose of pfizer 11/17/2021, 1 dose of moderna 4/6/2021
Lost sense of taste completely one week later 4/10 for one week through 4/16. Sense of small only slightly affected. Very alarming.
Skin colored lump at side immediately two hours later lymph node swelling on let side of neck.  Next pm. both sides of neck swelling, site itching at site, hives next day, saw medical doctor 2 days later.  "Not feeling well".  Took BENADRYL-took script for AVELOX, PREDNISONE.
3mins post vaccination, pt had dizziness and nausea that resulted in a syncopal event.   Vitals: 17:50 (trendelenburg) 93/65, 74, 12 SpO2 99% -- > 17:58 (supine) 99/67, 79, 12, 100% -- > 18:06 (sitting) 98/68, 84, 12, 100% Pt stable and released from the vaccination site.  Advised to notify PCP of event and to take the 2nd dose in the supine position.
Joint pain in the right hip; other joint; body hurting; Joint pain in the right hip; other joint; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 6 year-old male patient received bnt162b2 (BNT162B2), administration date 29Nov2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARTHRALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 01Dec2021, outcome "recovering" and all described as "Joint pain in the right hip; other joint"; PAIN (non-serious) with onset 01Dec2021, outcome "recovering", described as "body hurting". Additional information: The reporter stated that he had a question regarding a patient who had got recently (incomplete sentence) he was 6 years old (reporter was unsure) the patient got his COVID vaccine on last Monday. Two days after that the patient started some (incomplete sentence). The reporter attributed that to the vaccination but the reporter just wanted to make sure because reporter had two questions based on that. So two days later the patient started off with a 'single' joint pain in the right hip and then a couple of days later the patient complained about the other joint and body hurting. The patient didn't had a fever or any others problem expect the joint pain and the patient continued to have the symptoms probably the next, suddenly like 2 days after he received the vaccine, it had continued since then. The patient symptoms getting a little bit better and we are (voice not clear) to it, so usually the reporter would expect it (incomplete sentence). The reporter did not know that COVID could be seen as a little bit of 'prolongation' symptoms. So the reporter question was there any contraindication to receiving the vaccination, the second dose for this child and how long can they expect to see these symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
received COVID #2 on Thursday 2/4/21 in the morning. The next morning, developed a rash to my neck, ears, back and abdomen, with a little on my arms and legs. Its pruritic, lesions come and go, are erythematous, raised. No blisters, pustules or tenderness. No oral/face/throat/tongue swelling, watery eyes, SOB, wheeze, cough, CP, n/v/d. Photos sent and reviewed which demonstrate remarkable coalescing urticaria to trunk. improved with Zyrtec 10 q12
Boostrix administered instead of Infanrix; 18 months old / Boostrix administered instead of Infanrix; This case was reported by a physician via sales rep and described the occurrence of accidental underdose in a 18-month-old patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced accidental underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the accidental underdose and inappropriate age at vaccine administration were unknown.  Additional details were provided as follows: The physician reported that 18 moths old patient received Boostrix instead of Infanrix, which led to accidental underdose and inappropriate age at vaccine administration. The patient did not experienced any adverse events. No further information was reported.
Systemic: Fainting / Unresponsive-Mild, Systemic: Nausea-Mild, Additional Details: patient sat for about 5 minutes after vaccine. husband called us because she fainted. she became responsive a few minutes later. she did not want us to use epipen. given water. called 911. she was taken for observation
48hrs post MMR developed 8 1/2 x 9 1/2 induration and erythema non tender L deltoid.
Patient denies any significant history of headache. About one hour after second dose of Pfizer vaccine, she developed a progressive headache that ultimately led to Urgent care visit that evening. Discharged but then returned to ER overnight due to worsened headache. HCT negative.  headache continued next four days.  4/23/21 developed diplopia. 4/25 returned to ER due to this and increase in headache. Findings of papilledema, HCT again negative. Lab work with mild leukocytosis ~13 and thrombocytosis ~490. LP opening pressure >55mm H2O with diagnosis of Intracranial Hypertension. Acetazolamide started.  Neurology consult 4/28/21 showing R eye abducens palsy. MRI/MRV with contrast  4/29/21 shows severely narrowed transverse sinuses but NO evidence for venous sinus thrombosis. Currently awaiting catheter venography to confirm this with consideration of further management.  Adverse event appears to be potential acute exacerbation of Intracranial hypertension related to possible baseline anatomic narrowing of transverse venous sinuses. currently further evaluation to try and absolutely rule out acute venous sinus thrombosis though no evidence of this on MRVenogram with gadolinium contrast.
later in the evening, i started to have spasms below the injection site on my left arm. In formed this also to the pharmacist where I received my shot. She stated she would document in my file as and asked my if I was still having the symptoms.  I informed her, my last spasm occurred  08/21/2021. I received my second shot on 08/25/21. Within two hours, my arm started hurting extremely, which I knew it possibly would, however, it also raised quite a bit and was warm to touch as well. The raised bump lasted for three weeks. Also, since receiving  the second shot, my left pinky has gone numb.  I reported this to the pharmacist as my two family members waited to receiver their second shot. He stated he did not hear anything like this and appeared puzzled.  Like it had nothing to do with the shot. after a further conversation with him, he finally stated he would document in my record on file.
Patient reports feeling unwell after injection.  She felt like "throat was swollen."  Also reports having nausea/vomiting, fatigue and headache that persisted until 2/9/2021 (approximately 2-3 days after injection).  She did not eat Saturday and Sunday (day of the injection and day after injection).  She was finally feeling able to eat on 2/9/2021.  She also reported sensation of heart going "fast" up to 93 on Sunday (2/7/2021).  She denies any fevers or diarrhea.  She also developed soreness in left arm at area of injection site, but did not have any redness at injection site.
diarrhea, chills, fever, headache, tiredness, muscle pain, and sore arm.
Apprehension, Feeling faint/fuzzy. States feeling similar to reaction that occurred after IV dye. Rested - felt better - Released
Severe chills almost seizure like for at least 2 hours no fever until the morning 100.9
Individual got nauseous after 15 minutes, she was also a little dizzy.  It has been a day, and she is still nauseous.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 10:12 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 10:12 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 77.93.  Concomitant products were not provided.  On 31-Mar-2021, Excursion time was 08 AM and 09 AM, temperature was 32, total doses given for the day was 199, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 31-Mar-2021. 14 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021.   On 31-Mar-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 32, 9 AM: 32, 10 AM: 40, 11 AM: 42, 12 AM: 43, 1PM: 44, 2 PM: 46, 3 PM: 46, 4 PM: 44 and 5 PM: 44.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Patient is a 35-year-old female 1 day status post first dose of Moderna COVID-19 vaccination.  Patient was found to have sinus tachycardia, fever, with palpitations consistent with adverse vaccine reaction.  Patient was treated with IV fluids, acetaminophen and vital signs normalized.  Patient feels better at discharge. Patient was noted to have a mildly decreased TSH on testing and this should be followed up with her primary care physician.
Vaccine administered at 08:16--08:25 patient c/o feeling unwell and dizzy 87, 143/84, 18, 100%; 08:28: Pt c/o dizzy & chest tightness, appeared pale, monitoring; 08:34: Pt c/o increased chest tightness 130, 144/81, 22, 100% monitoring 08:36: Epinephrine .3mg given IM to R thigh, pt. reported flushing, pounding heart, 911 called; 08:40: Pt flushed.
Discharge Provider:  MD  Primary Care Provider :  FNP    Admission Date: 2/1/2023 Deceased Date:  Date of Death: 2/4/23 Time of Death:  8:08 AM Preliminary Cause of Death: Myocardial infarction (HCC)       Admitting Diagnoses: Pneumonia due to infectious organism   HOSPITAL COURSE: Patient is a 89 y.o. female with past medical history significant for dementia, DVT and pulmonary embolism on Coumadin, hypertension hyperlipidemia, osteoarthritis, iron deficiency anemia, gastroesophageal reflux disease, presenting to an inpatient unit as a transfer from a local Emergency Department where she had presented with chief complaint of increased fatigue, multiple falls, cough, diarrhea, and increased confusion.  Patient lives with her daughter and the falls were happening as she was trying to get off the toilet, no history of head injury.  No history of fever.  It should be noted, that patient is a very poor historian and most of information is obtained from reviewing chart and speaking with the emergency physician   In the emergency department, patient was hypotensive with blood pressure of 84/64 and hypoxic with oxygen saturation of 81% on room air.  Laboratory value with evidence of hypernatremia with sodium 147, hypokalemia with potassium of 3.4, acute kidney injury superimposed on chronic kidney disease stage 3 with BUN of 42, creatinine 1.12, and GFR of 47, liver enzymes elevated with ALT of 42, AST of 66, and alk phosphatase of 111. Initial lactic acid 4.6 decreased to 2.9 after sepsis fluid bolus.  Complete blood count with no evidence of leukocytosis but hematocrit elevated at 48. INR elevated at 6.2 with PT of 56.    COVID-19 PCR detected.  Urinalysis positive for leukocyte esterase, large amount of blood, many bacteria, greater than 180 wbc's, many WBC clumps.  CT head without contrast with no acute intracranial abnormality.  A 3.5 mm nodularity at the left middle cerebral artery trifurcation possible aneurysm.  Two-view chest x-ray with evidence of large hiatal hernia, right lung base opacity concerning for infection.  Left hip x-ray with no evidence of fracture or dislocation, evidence of severe right femoral acetabular joint degenerative changes.   In the emergency department, patient was fluid resuscitated per sepsis guidelines.  Peripheral blood cultures and urine culture were obtained.  Patient was started on IV ceftriaxone and IV doxycycline, and IVF.  She was not hypoxic and with volume resuscitation became hemodynamically stable.  She was confused with was her baseline but remained weak and fairly somnolent despite treatment of her pneumonia.  Since she was not hypoxic she was not given steroids or remdesivir for COVID.  Due to her weakness, SAR or ECF was recommended.  Family asked about hospice care and if they could take her home with hospice.  They did meet with hospice and planned on discharge to home on  2/5.  Unfortunately, the patient developed atrial fibrillation in the setting of a STEMI.  She became hypoxic and since hospice was already being planned no aggressive interventions were carried out.  She was started on a morphine drip and subsequently expired the morning of 2/4.
In the morning of May 2nd I was driving and I felt my heart rate increasing lasted about 30 minutes to an hour. I ended up going to the ER and I was diagnosed with sinus tachycardia, I stayed overnight. After that event I developed a cognitive fog and a sensation of numbness on the left side of my head like someone is pulling the skin on my face ever so slightly. I also developed a sense of imbalance like I am in a boat for an extended period of time. These feelings remained constant and I noticed that they were getting better by May 19th. At 6 am on May 19th I walk up to the feeling of my heart pounding and my heart rate increasing, I measured my pulse on my watch and it was around 150 bpm average. This event lasted about 5 minutes and went away. On May 19th around 10 pm I was in the shower and my heart rate increase again and I felt a tickling sensation on the left side of my chest when I was breathing in. I ended up going to the ER gain and stayed overnight. May 26th I felt the sensations of fogginess and just feeling off cognitively. May 27th I woke up rested without fogginess and after a morning walk with my dog I felt my heart increasing. This episode lasted about 10-20 minutes and my heart rate was ranging between 120-150 bpm. My stools from April 20th till May 26th have been lighter in color yellowish and soft, when I consumed vegetables I could see specs of them in my stools like they were not fully processed. May 27th was the first day where my stool color was brown but still soft.
Case number PHEH2013US015551, is an initial spontaneous report received from the nurse on 18 Jul 2013. This report refers to an 11-year-old male patient. His medical history and concomitant medications was not reported. He was vaccinated with 0.5 ml of MENVEO (batch number: A12011, expiry date: Feb 2014) intramuscularly on 12 Jul 2013. On 14 Jul 2013, he experienced redness, swelling and hardness at vaccination site and he also experienced temperature of 100 F. He was taken to urgent care practitioner where he was diagnosed with cellulitis. He was prescribed BACTRIM. The event outcome, seriousness and causality were not reported.
rt arm sore day p/vax but resolved 29MAR97 rt arm became sore, inc soreness, itching 30MAR97;called MD who told said come to clinic;exam by MD swelling, redness, firmness, painful from shoulder to elbow;dx hypersensitivity rxn-arthus type;
Information has been received from a physician assistant concerning unspecified patients. The patient's concomitant medications, pertinent medical history, and drug reactions and allergies have not been provided. On unspecified dates these patients were administered improperly stored VAQTA (lot # M022531, expired date 23-FEB-2018) (dose and frequency were unknown). The VAQTA was stored at 46.8 F for 4 hours 30 minutes. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.